Evaluation of self-dissolving needles containing low molecular weight heparin (LMWH) in rats.

[1]  Kanji Takada,et al.  Feasibility of microneedles for percutaneous absorption of insulin. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  Mark G. Allen,et al.  Polymer Microneedles for Controlled-Release Drug Delivery , 2006, Pharmaceutical Research.

[3]  J. Yoshimitsu,et al.  Self-dissolving microneedles for the percutaneous absorption of EPO in mice , 2006, Journal of drug targeting.

[4]  Mark G. Allen,et al.  Hollow metal microneedles for insulin delivery to diabetic rats , 2005, IEEE Transactions on Biomedical Engineering.

[5]  Melissa Ai Ling Teo,et al.  In Vitro and In Vivo Characterization of MEMS Microneedles , 2005, Biomedical microdevices.

[6]  Mahmoud Ameri,et al.  Transdermal delivery of desmopressin using a coated microneedle array patch system. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Wijaya Martanto,et al.  Transdermal Delivery of Insulin Using Microneedles in Vivo , 2004, Pharmaceutical Research.

[8]  Véronique Préat,et al.  Skin electroporation for transdermal and topical delivery. , 2004, Advanced drug delivery reviews.

[9]  G. Cevc.  Lipid vesicles and other colloids as drug carriers on the skin. , 2004, Advanced drug delivery reviews.

[10]  S. Mitragotri,et al.  Low-frequency sonophoresis: a review. , 2004, Advanced drug delivery reviews.

[11]  N. Kollias,et al.  Transdermal drug delivery with a pressure wave. , 2004, Advanced drug delivery reviews.

[12]  C. Ahn,et al.  A tapered hollow metallic microneedle array using backside exposure of SU-8 , 2004 .

[13]  Shankar Chandrasekaran,et al.  Surface micromachined metallic microneedles , 2003 .

[14]  W. Ageno.  Treatment of venous thromboembolism , 2002, International journal of hematology.

[15]  Dorian Liepmann,et al.  Microfabricated Polysilicon Microneedles for Minimally Invasive Biomedical Devices , 2000 .

[16]  B. Boneu.  Low molecular weight heparins: are they superior to unfractionated heparins to prevent and to treat deep vein thrombosis? , 2000, Thrombosis research.

[17]  J. Heit.  Low-Molecular-Weight Heparin: Biochemistry, Pharmacology, and Concurrent Drug Precautions , 1998, Regional Anesthesia & Pain Medicine.

[18]  J. Hirsh,et al.  Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. , 1992, Chest.

[19]  B. Asmussen.  Transdermal therapeutic systems--actual state and future developments. , 1991, Methods and findings in experimental and clinical pharmacology.

[20]  D. Lane,et al.  Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4. , 1984, The Biochemical journal.

[21]  Catherine G. Ambrose,et al.  Bioabsorbable Implants: Review of Clinical Experience in Orthopedic Surgery , 2004, Annals of Biomedical Engineering.

[22]  G. Stemme,et al.  Micromachined barbed spikes for mechanical chip attachment , 2002 .

[23]  G. Agnelli,et al.  Prevention of venous thromboembolism. , 2000, Thrombosis research.